To evaluate whether the antihyperglycemic actions of CIN and AITC are mediated by increased Glucagon-like peptide-1 (GLP-1) secretion, this incretin was measured by collecting serum during the glucose tolerance test, after administration of CIN and AITC, in vivo. Here, GCG is linked to cervical squamous intraepithelial neoplasia.